...
机译:新型AP3B1 AP3B1复合日本患者中的杂合酶突变与Hermansky-Pudlak综合征2型
Department of PediatricsKagoshima UniversityKagoshima Japan;
Department of DermatologyYamagata UniversityYamagata Japan;
Department of PediatricsKagoshima UniversityKagoshima Japan;
Lalala Children’s ClinicKagoshima Japan;
Departments ofKagoshima UniversityKagoshima Japan;
Department ofKagoshima UniversityKagoshima Japan;
Department ofKagoshima UniversityKagoshima Japan;
Research InstituteBML Inc.Tokyo Japan;
Departments ofTokyo Medical and Dental UniversityTokyo Japan;
Departments ofKagoshima UniversityKagoshima Japan;
Department ofTokyo Medical and Dental UniversityTokyo Japan;
Department of DermatologyYamagata UniversityYamagata Japan;
Department of PediatricsKagoshima UniversityKagoshima Japan;
adaptor‐related protein complex 3; Hermansky–Pudlak syndrome type 2; immunodeficiency; oculocutaneous albinism; platelet aggregation disorder;
机译:新型AP3B1 AP3B1复合日本患者中的杂合酶突变与Hermansky-Pudlak综合征2型
机译:通过染色体5倒置破坏AP3B1:2型赫曼斯基-普德拉克综合征的新发病机制
机译:AP-3衔接子复合物的beta3A亚基基因(Ap3b1)在小鼠色素沉着突变型珍珠(Hermansky-Pudlak综合征和夜盲症的模型)中发生了改变。
机译:通过成骨不全症类型鉴定导致骨骼脆弱的NBAS中的新型复合杂合变体
机译:使用重组突变体/野生型p53杂合性人类乳腺上皮细胞培养模型确定p53突变在人类乳腺癌进展中的作用。
机译:两名2型Hermansky Pudlak综合征患者和AP3B1的新突变
机译:两名2型Hermansky Pudlak综合征患者和AP3B1的新突变